Novartis Aktie

140,48 EUR -1,32 EUR -0,93 %

18:34:44

L&S

128,10 CHF -1,70 CHF -1,31 %

17:36:42

SWX

Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.271,13 Mrd. EUR

KGV18,30Div. Rendite3,38%

WKN904278

ISINCH0012005267

SymbolNVSEF

Novartis Aktien News

Sortieren:Datum Meistgelesen

16.12.25ZacksThe Zacks Analyst Blog Microsoft, Novartis, RTX and Air T

15.12.25ZacksTop Research Reports for Microsoft, Novartis & RTX

12.12.25Dow JonesPress Release: Novartis breaks ground on flagship manufacturing hub in North Carolina

10.12.25BenzingaSTAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process

09.12.25Business TimesNovartis strikes deal with UK biotech for up to US$1.7 billion

09.12.25Dow JonesPress Release: 1 in 4 metastatic breast cancer -2-

09.12.25Dow JonesPress Release: 1 in 4 metastatic breast cancer patients treated with Novartis Kisqali(R) remain progression-free beyond 4 years

05.12.25BenzingaPrice Over Earnings Overview: Novartis

03.12.25MotleyFoolHealthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms

03.12.25ZacksHere's Why Novartis (NVS) is a Strong Value Stock

27.11.25ZacksHere's Why Novartis (NVS) is a Strong Momentum Stock

26.11.25MotleyFoolWhy Novartis Stock Topped the Market Today

25.11.25BenzingaFDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults

24.11.25Dow JonesPress Release: Novartis receives FDA approval for -2-

24.11.25Dow JonesPress Release: Novartis receives FDA approval for Itvisma(R), the only gene replacement therapy for children two years and older, teens, and adults with spin...

20.11.25BenzingaNovartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

18.11.25BenzingaIs the Market Bullish or Bearish on Novartis AG?

14.11.25ZacksHere's Why Novartis (NVS) is a Strong Value Stock

12.11.25Dow JonesPress Release: Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial r...

12.11.25BenzingaNew Eye Tech Is Booming For Alcon, Stock Soars

12.11.25BenzingaAlcon, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday

12.11.25ZacksAlcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

10.11.25Dow JonesPress Release: Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan

06.11.25ZacksCurious about Alcon (ALC) Q3 Performance? Explore Wall Street Estimates for Key Metrics

04.11.25Dow JonesPress Release: New Novartis data at ASN Kidney -2-

04.11.25Dow JonesPress Release: New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline

29.10.25Dow JonesPress Release: Novartis ianalumab first drug to -2-

29.10.25Dow JonesPress Release: Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren's disease Phase III trials

29.10.25BenzingaIs the Market Bullish or Bearish on Novartis AG?

29.10.25ZacksWhy Novartis (NVS) is a Top Value Stock for the Long-Term

28.10.25ZacksNovartis Lags Q3 Earnings, Announces $12B Avidity Biosciences Acquisition

28.10.25Dow JonesPress Release: Novartis completes acquisition of Tourmaline Bio

28.10.25ZacksCompared to Estimates, Novartis (NVS) Q3 Earnings: A Look at Key Metrics

28.10.25BenzingaNovartis Maintains Outlook Even As Generics Bite Into Profits

28.10.25Business TimesNovartis Q3 operating income up 6% on new drug sales

28.10.25Dow JonesPress Release: Novartis announces expiration of Tourmaline Bio tender offer

28.10.25Dow JonesPress Release: Novartis delivers solid sales and -3-

28.10.25Dow JonesPress Release: Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance

27.10.25BenzingaAvidity Biosciences Soars After $72 Per Share Novartis Takeover

27.10.25BenzingaAvidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal

Novartis News

Novartis News: auf dieser Seite finden Sie alle Novartis News und Nachrichten zur Novartis Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novartis News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novartis News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.